Search
for
Sort by
Research 31–60 of 280
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Treatment of Chemotherapy Induced Alopecia
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Cancer-Related Alopecia Risk and Treatment
- Alopécia Permanente Pós-Quimioterapia com Resposta Favorável ao Minoxidil Tópico
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- The financial burden of scalp cooling therapy: A nonprofit organization data analysis
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Assessment of hair loss and skin changes during treatment in Asian breast cancer patients: A prospective cohort study
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- Scalp Cooling for Chemotherapy-Induced Alopecia in Breast Cancer: A Recent Literature Review
- Objective quantification of chemotherapy-induced madarosis: a pilot study of an automated computer vision pipeline for eyebrow density assessment
- Clinical and genetic predictors of persistent chemotherapy-induced alopecia despite scalp cooling in breast cancer
- 269 Scalp cooling for chemotherapy-induced alopecia in skin of color patients: An interventional study
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Prostate cancer update: 2007
- Disruption of microtubules with low intensity ultrasound rescues hair follicle damage by paclitaxel in mouse models
- [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].
- Scalp cooling versus standard cold-cap in preventing chemotherapy-induced alopecia in patients with localized breast cancer: ICELAND protocol, a randomized controlled trial and economic evaluation
- ISID1403 - Melatonin protects K15+ human hair follicle stem cells against paclitaxel-induced damage ex vivo
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies